NeuroPace

The 3-year results of the RNS® System Post-Approval Study are here. Dr. Dawn Eliashiv — renowned epileptologist, researcher, and leader in the field — will present the long-term data on brain-responsive neuromodulation and what it means for patients with drug-resistant focal epilepsy. 🗓 Monday, April 7 | 5:06 PM PT 📍 San Diego Convention Center | 29A This is data-driven insight from a leading expert—don’t miss it. Learn more: https://lnkd.in/gAeku8qv Important Safety Info: www.neuropace.com/safety

How does the RNS® System compare in long-term seizure reduction? The 3-year results from the RNS System Post-Approval Study have the answer. 🗓 Monday, April 7 | 5:06 PM PT 📍 San Diego Convention Center I 29A Be among the first to see the data from the largest FDA-reviewed prospective study in neuromodulation for focal drug-resistant epilepsy. 🔗 Learn more: https://lnkd.in/gAeku8qv Important Safety Info: www.neuropace.com/safety

🎉Congratulations to Dr. Erik Larson and Dr. Cliff Hampton at Kootenai Health on completing the first RNS System case in Idaho, bringing new hope to patients with drug-resistant #epilepsy. This young woman has battled seizures since childhood, experiencing daily episodes that impacted her safety, independence, and ability to work. After trying multiple medications without success, she now has the RNS System—a breakthrough in responsive neurostimulation designed to help reduce #seizures in real time. With leaders like Dr. Larson pushing the boundaries of epilepsy care, more patients have the opportunity to regain control of their lives. RNS Safety Info: www.neuropace.com/safety

We're #hiring a new Downstream Senior Marketing Manager in Mountain View, California. Apply today or share this post with your network.

✨ Celebrating Innovation at NeuroPace! ✨ We recently hosted our first-ever NeuroPace Inventor Recognition Dinner, honoring the brilliant minds behind our technology. This special evening recognized 11 inventors, many who have been with us since our IPO. These inventors are shaping the future of neurotechnology with their groundbreaking contributions. A special congratulations to three of our inventors, Steve Archer, Tom Tcheng, Ph.D., and Patrick Mulligan who received monetary awards for their invaluable contributions to our growing patent portfolio! Their innovation continues to drive our mission forward, improving the lives of those with epilepsy. Thank you to all our inventors—past and present—who make NeuroPace a leader in the field! #Innovation #NeuroPace #MedicalTechnology #Inventors #MedTech #NeuroTech

Do you have questions about the RNS System? Ask an #epilepsy specialist during our Q&A session: https://lnkd.in/gufJJrku 🗓️Free webinar: Tue 2/11, at 5pm PT/8pm ET Safety Info: www.neuropace.com/safety

We're #hiring a new Enterprise Applications Support Specialist in Mountain View, California. Apply today or share this post with your network.

We're #hiring a new Patient Educator/Nurse Navigator in New York, New York. Apply today or share this post with your network.

👏 Congratulations to Dr. Winer, neurosurgeon, Cindy, Neurosurgical Specialty Coordinator, and the incredible team at Wellspan Epilepsy Center for successfully completing their first RNS System case! This milestone marks a significant step forward in providing advanced treatment options for individuals living with drug-resistant focal epilepsy. By adopting cutting-edge technology like the RNS System, the team is paving the way for more patients to gain access to personalized and effective care.   A huge thank you to the physicians, staff, and everyone involved for their dedication to improving lives and expanding access to innovative solutions in epilepsy treatment. Safety Info: neuropace.com/safety/ #EpilepsyAwareness #InnovationInHealthcare #RNSSystem 

We're #hiring a new Executive Assistant to the CEO, General Counsel and CFO in Mountain View, California. Apply today or share this post with your network.